Drugmaker Ipca Laboratories on Saturday reported a 38 percent rise in consolidated net profit at Rs 266.7 crore for the second quarter ended September 30, 2020. The company had posted a net profit of Rs 193.5 crore for the year-ago period.
Revenue from operations rose to Rs 1,361.1 crore in the quarter as against Rs 1,283.9 crore in the same period a year ago, Ipca Labs said in a regulatory filing.
On a standalone basis, the company posted a net profit of Rs 275.68 crore, up 41 percent from Rs 196.02 crore in July-September 2019-20. The company's board has declared an interim dividend of Rs 8 per share (400 percent) for 2020-21, Ipca Labs said.
(Edited by : Jomy)
First Published: Nov 7, 2020 4:34 PM IST
